Personalized and precision medicine as a unique healthcare model to secure the national and international biosafety

---

Sergey Suchkov, Hiroyuki Abe, Shawn Murphy, Vladimir Lazar and John Mendelsohn

Moscow Engineering Physical Institute (MEPhI), Russia
Autoimmunity Research Foundation, USA
Partners Healthcare International, USA
WIN Consortium, France
University of Texas MD Anderson Cancer Center, USA

: J Nephrol Ren Dis

Abstract

---

A new systems approach to diseased states and wellness result in a new branch in the healthcare services, namely, personalized medicine (PM). To achieve the implementation of PM concept, it is necessary to create a fundamentally new strategy based upon the subclinical recognition of biopredictors of hidden abnormalities long before the disease clinically manifests itself. Each decision-maker values the impact of their decision to use PM on their own budget and well-being, which may not necessarily be optimal for society as a whole. It would be extremely useful to integrate data harvesting from different databanks for applications such as prediction and personalization of further treatment to thus provide more tailored measures for the patients resulting in improved patient outcomes, reduced adverse events, and more cost effective use of health care resources. A lack of medical guidelines has been identified by the majority of responders as the predominant barrier for adoption, indicating a need for the development of best practices and guidelines to support the implementation of PM! Implementation of PM requires a lot before the current model “physician-patient” could be gradually displaced by a new model “medical advisor-healthy person-atrisk”. This is the reason for developing global scientific, clinical, social, and educational projects in the area of PM to elicit the content of the new branch.

Biography

---

E-mail: ssuchkov57@gmail.com